CDC, FDA Reviewing Higher Myocarditis Risk in Under 30’s for Moderna Jab
Read the ArticleUpdated
Federal health officials are investigating emerging reports that the Moderna coronavirus vaccine may be associated with a higher risk of a heart condition called myocarditis in younger adults than previously believed, according to two people familiar with the review who emphasized the side effect still probablyremains uncommon.
The investigation, which involves the Food and Drug Administration and the Centers for Disease Control and Prevention, is focusing on Canadian data that suggests the Moderna vaccine may carry a higher risk for young people than the Pfizer-BioNTech vaccine, especially for males below the age of 30 or so. The authorities also are scrutinizing data from the United States to try to determine whether there is evidence of an increased risk from Moderna in the U.S. population.
READ FULL REPORT HERE:
https://www.washingtonpost.com/health/2021/08/19/moderna-vaccine-myocarditis/
